Literature DB >> 30094591

Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review.

Jamison Pike1, Scott D Grosse2.   

Abstract

Cost-of-illness (COI) studies often include the 'indirect' cost of lost production resulting from disease, disability, and premature death, which is an important component of the economic burden of chronic conditions assessed from the societal perspective. In most COI studies, productivity costs are estimated primarily as the economic value of production forgone associated with loss of paid employment (foregone gross earnings); some studies include the imputed value of lost unpaid work as well. This approach is commonly but imprecisely referred to as the human capital approach (HCA). However, there is a lack of consensus among health economists as to how to quantify loss of economic productivity. Some experts argue that the HCA overstates productivity losses and propose use of the friction cost approach (FCA) that estimates societal productivity loss as the short-term costs incurred by employers in replacing a lost worker. This review sought to identify COI studies published during 1995-2017 that used the FCA, with or without comparison to the HCA, and to compare FCA and HCA estimates from those studies that used both approaches. We identified 80 full COI studies (of which 75% focused on chronic conditions), roughly 5-8% of all COI studies. The majority of those studies came from three countries, Canada, Germany, and the Netherlands, that have officially endorsed use of the FCA. The FCA results in smaller productivity loss estimates than the HCA, although the differential varied widely across studies. Lack of standardization of HCA and FCA methods makes productivity cost estimates difficult to compare across studies.

Entities:  

Mesh:

Year:  2018        PMID: 30094591      PMCID: PMC6467569          DOI: 10.1007/s40258-018-0416-4

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN: 1175-5652            Impact factor:   2.561


  97 in total

Review 1.  Theory versus practice: a review of 'willingness-to-pay' in health and health care.

Authors:  J A Olsen; R D Smith
Journal:  Health Econ       Date:  2001-01       Impact factor: 3.046

2.  Social Cost of Substance Abuse in Russia.

Authors:  Elena Potapchik; Larisa Popovich
Journal:  Value Health Reg Issues       Date:  2014-05-13

Review 3.  The impact of indirect costs on outcomes of health care programs.

Authors:  M A Koopmanschap; F F Rutten
Journal:  Health Econ       Date:  1994 Nov-Dec       Impact factor: 3.046

4.  Productivity loss resulting from coronary heart disease in Australia.

Authors:  Henry Zheng; Fred Ehrlich; Janaki Amin
Journal:  Appl Health Econ Health Policy       Date:  2010       Impact factor: 2.561

5.  Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison.

Authors:  Simone Neubauer; Robert Welte; Alexandra Beiche; Hans-Helmut Koenig; Katharina Buesch; Reiner Leidl
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

6.  Economic evaluation of multiple sclerosis in the UK, Germany and France.

Authors:  N Murphy; C Confavreux; J Haas; N König; E Roullet; M Sailer; M Swash; C Young; J L Mérot
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

7.  Economic burden of cardiovascular diseases in Serbia.

Authors:  Dragana Lakić; Ljiljana Tasić; Mitja Kos
Journal:  Vojnosanit Pregl       Date:  2014-02       Impact factor: 0.168

8.  Estimating the social cost of respiratory cancer cases attributable to occupational exposures in France.

Authors:  Hassan Serrier; Hélène Sultan-Taieb; Danièle Luce; Sophie Bejean
Journal:  Eur J Health Econ       Date:  2013-08-24

9.  Lost productivity due to premature mortality in developed and emerging countries: an application to smoking cessation.

Authors:  Joseph Menzin; Jeno P Marton; Jordan A Menzin; Richard J Willke; Rebecca M Woodward; Victoria Federico
Journal:  BMC Med Res Methodol       Date:  2012-06-25       Impact factor: 4.615

10.  Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges.

Authors:  Ramesh Lamsal; Jennifer D Zwicker
Journal:  Appl Health Econ Health Policy       Date:  2017-12       Impact factor: 2.561

View more
  34 in total

1.  Excess costs of mental disorders by level of severity.

Authors:  Hannah König; Hans-Helmut König; Jürgen Gallinat; Martin Lambert; Anne Karow; Judith Peth; Holger Schulz; Alexander Konnopka
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2022-05-31       Impact factor: 4.328

2.  Productivity Loss and Associated Costs Among Patients with Transfusion-Dependent Thalassemia in Dubai, United Arab Emirates.

Authors:  Shaikha Alshamsi; Samer Hamidi; Hacer Ozgen Narci
Journal:  Clinicoecon Outcomes Res       Date:  2021-09-29

3.  Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations.

Authors:  Scott D Grosse; Kurt V Krueger; Jamison Pike
Journal:  J Med Econ       Date:  2018-11-15       Impact factor: 2.448

4.  Societal Costs of a Measles Outbreak.

Authors:  Jamison Pike; Alan Melnick; Paul A Gastañaduy; Meagan Kay; Jeff Harbison; Andrew J Leidner; Samantha Rice; Kennly Asato; Linda Schwartz; Chas DeBolt
Journal:  Pediatrics       Date:  2021-03-12       Impact factor: 7.124

Review 5.  Economic assessments of the burden of congenital cytomegalovirus infection and the cost-effectiveness of prevention strategies.

Authors:  Scott D Grosse; Sheila C Dollard; Ismael R Ortega-Sanchez
Journal:  Semin Perinatol       Date:  2021-01-23       Impact factor: 3.300

Review 6.  Monetary Valuation of Children's Cognitive Outcomes in Economic Evaluations from a Societal Perspective: A Review.

Authors:  Scott D Grosse; Ying Zhou
Journal:  Children (Basel)       Date:  2021-04-29

7.  Production losses attributable to suicide deaths in European Union.

Authors:  Błażej Łyszczarz
Journal:  BMC Public Health       Date:  2021-05-19       Impact factor: 3.295

8.  [Newborn screening for congenital hypothyroidism and congenital adrenal hyperplasia: Benefits and costs of a successful public health program].

Authors:  Guy Van Vliet; Scott D Grosse
Journal:  Med Sci (Paris)       Date:  2021-05-18       Impact factor: 0.716

9.  Adjusted productivity costs of stroke by human capital and friction cost methods: a Northern Finland Birth Cohort 1966 study.

Authors:  Ina Rissanen; Leena Ala-Mursula; Iiro Nerg; Marko Korhonen
Journal:  Eur J Health Econ       Date:  2021-02-24

10.  Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption.

Authors:  Beata Gavurova; Miriama Tarhanicova
Journal:  Int J Environ Res Public Health       Date:  2021-05-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.